Gastroesophageal Junction Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +27 more
  • Anchorage, Alaska
  • +429 more
2022-01-11
Jan 11, 2022
E
Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +5 more
2022-01-10
Jan 10, 2022
S
Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • ladiratuzumab vedotin
  • Chandler, Arizona
  • +64 more
2022-01-07
Jan 7, 2022
O
Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Scottsdale, Arizona
  • +30 more
2021-12-30
Dec 30, 2021
F
Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Media Intervention
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-05
Jan 5, 2022
A
Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +3 more
2022-01-05
Jan 5, 2022
A
Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Duarte, California
  • +1 more
2022-01-06
Jan 6, 2022
H
Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TAS 102
  • Ramucirumab 10 MG/ML Intravenous Solution [CYRAMZA]
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-12-28
Dec 28, 2021
E
No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
2021-12-16
Dec 16, 2021
T
Not yet recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
2021-12-01
Dec 1, 2021
T
Not yet recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
2021-12-01
Dec 1, 2021
K
Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Guangzhou, Guangdong, China
  • +2 more
2021-11-25
Nov 25, 2021
A
Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +19 more
2021-12-03
Dec 3, 2021
N
Active, not recruiting
  • Esophageal Adenocarcinoma
  • +6 more
  • Birmingham, Alabama
  • +633 more
2021-12-03
Dec 3, 2021
A
Recruiting
  • Solid Tumor
  • +8 more
  • APL-101 Oral Capsules
  • Gilbert, Arizona
  • +93 more
2021-11-23
Nov 23, 2021
M
Recruiting
  • Esophagogastric Cancer
  • +6 more
  • 18F-BMS-986229 Injection
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-11-12
Nov 12, 2021
F
Not yet recruiting
  • Gastric Neoplasms
  • Gastroesophageal Junction Adenocarcinoma
  • Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
2021-10-27
Oct 27, 2021
D
Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
2021-11-02
Nov 2, 2021
T
Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Ann Arbor, Michigan
  • +6 more
2021-10-20
Oct 20, 2021
V
Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Stomach Neoplasms
  • Avelumab addition to perioperative chemotherapy in GC and GEJC
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
2021-10-04
Oct 4, 2021
M
Active, not recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
2021-09-22
Sep 22, 2021